DXCM — Dexcom

Health Care Equipment · Health Care

S&P 500 Timeline

2020-05-12Joined S&P 500
Dexcom designs and commercializes continuous glucose monitoring (CGM) systems for diabetes patients. CGM systems serve as an alternative to traditional blood glucose meters. The company is developing its CGM system for integration with insulin pumps manufactured by Insulet and Tandem, enabling automated insulin delivery. Dexcom's CGM products are available through medical device distributors and retail pharmacies.

Key Facts

StatusActive
SectorHealth Care
IndustryHealth Care Equipment
Joined2020-05-12
Tenure6 yrs

Industry Peers

Sector Peers

Institutional Holdings (13F)

982 institutions hold DXCM, totaling 2.03B shares ($31.2B) · As of 2026Q1

RankInstitutionSharesValue
1VANGUARD CAPITAL MANAGEMENT LLC50.0M$3.1B
2BlackRock, Inc.153.5M$2.6B
3DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main306.2M$2.2B
4Employees Provident Fund Board17.4M$1.4B
5BARCLAYS PLC30.6M$1.3B
6VANGUARD PORTFOLIO MANAGEMENT LLC19.2M$1.2B
7STATE STREET CORP44.6M$1.2B
8BAILLIE GIFFORD & CO15.6M$980M
9MORGAN STANLEY19.9M$951M
10ALLIANCEBERNSTEIN L.P.12.9M$858M

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10